- Home
- MODV vs ACHV Comparison
MODV vs ACHV Comparison
Compare MODV & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODV
- ACHV
- Stock Information
- Founded
- MODV 1996
- ACHV N/A
- Country
- MODV United States
- ACHV Canada
- Employees
- MODV N/A
- ACHV N/A
- Industry
- MODV Transportation Services
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- MODV Consumer Discretionary
- ACHV Health Care
- Exchange
- MODV Nasdaq
- ACHV Nasdaq
- Market Cap
- MODV 172.6M
- ACHV 159.0M
- IPO Year
- MODV N/A
- ACHV N/A
- Fundamental
- Price
- MODV $16.84
- ACHV $4.53
- Analyst Decision
- MODV Buy
- ACHV Strong Buy
- Analyst Count
- MODV 4
- ACHV 4
- Target Price
- MODV $27.25
- ACHV $15.50
- AVG Volume (30 Days)
- MODV 257.6K
- ACHV 99.8K
- Earning Date
- MODV 11-06-2024
- ACHV 11-07-2024
- Dividend Yield
- MODV N/A
- ACHV N/A
- EPS Growth
- MODV N/A
- ACHV N/A
- EPS
- MODV N/A
- ACHV N/A
- Revenue
- MODV $2,787,619,000.00
- ACHV N/A
- Revenue This Year
- MODV $4.32
- ACHV N/A
- Revenue Next Year
- MODV $7.14
- ACHV N/A
- P/E Ratio
- MODV N/A
- ACHV N/A
- Revenue Growth
- MODV 3.16
- ACHV N/A
- 52 Week Low
- MODV $11.00
- ACHV $3.03
- 52 Week High
- MODV $52.33
- ACHV $5.98
- Technical
- Relative Strength Index (RSI)
- MODV 52.63
- ACHV 42.32
- Support Level
- MODV $15.34
- ACHV $4.32
- Resistance Level
- MODV $18.78
- ACHV $5.31
- Average True Range (ATR)
- MODV 1.11
- ACHV 0.20
- MACD
- MODV 0.24
- ACHV -0.04
- Stochastic Oscillator
- MODV 55.81
- ACHV 21.21
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. The company is also a provider of non-emergency medical transportation, or NEMT, personal care, and remote patient monitoring, or RPM, solutions, which serve similar, highly vulnerable patient populations. Its operating segment includes NEMT, Personal Care, and Remote Patient Monitoring. The company generates maximum revenue from the NEMT segment.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.